Literature DB >> 19545634

High level expression and purification of active recombinant human interleukin-8 in Pichia pastoris.

Hongbo Li1, Dongye Wang, Aimin Xu, Shiwu Li, Shouguang Jin, Donghai Wu.   

Abstract

Human interleukin-8 (hIL-8) is a member of interleukin family which functions as a chemotactic factor as well as an angiogenesis mediator. Previously, a study reported that hIL-8 could be purified from inclusion bodies using a prokaryotic expression system, however, the required re-naturation step limits the recovery of fully active protein. In this study, soluble recombinant hIL-8 was expressed as a secreted protein at high level in Pichia pastoris under the control of AOX1 (alcohol oxidase 1) promoter. A simple purification strategy was established to recover rhIL-8 from the fermentation supernatant. The process includes precipitation with 80% saturation ammonium sulfate and CM Sepharose ion exchange chromatography, yielding 30 mg/L purified rhIL-8 at over 95% purity. The obtained rhIL-8 displays high specific activity, stimulating the migration of mouse neutrophils at concentrations as low as 0.25 ng/mL. Our results demonstrate that P. pastoris expression system is an efficient tool for large-scale manufacture of active recombinant hIL-8 for various applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545634     DOI: 10.1016/j.pep.2009.06.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.

Authors:  Vindhya Vijay; Regan Miller; Gau Shoua Vue; Mida Bahareh Pezeshkian; Michael Maywood; Allison M Ast; Leylah M Drusbosky; Yuri Pompeu; Alan D Salgado; Samuel D Lipten; Timothy Geddes; Ann Marie Blenc; Yubin Ge; David A Ostrov; Christopher R Cogle; Gerard J Madlambayan
Journal:  Leuk Res       Date:  2019-07-03       Impact factor: 3.156

2.  A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.

Authors:  Fabrice Cerini; Hubert Gaertner; Knut Madden; Ilya Tolstorukov; Scott Brown; Bram Laukens; Nico Callewaert; Jay C Harner; Anna M Oommen; John T Harms; Anthony R Sump; Robert C Sealock; Dustin J Peterson; Scott K Johnson; Stephan B Abramson; Michael Meagher; Robin Offord; Oliver Hartley
Journal:  Protein Expr Purif       Date:  2015-10-24       Impact factor: 1.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.